BiotechTube

Emtricitabine and Tenofovir

ApprovedUNKNOWN
0 watching 0 views this week🔥 Hot
84
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

HIV/AIDS

Conditions

HIV/AIDS

Trial Timeline

Nov 1, 2016 → Nov 1, 2019

NCT ID
NCT03120494

About Emtricitabine and Tenofovir

Emtricitabine and Tenofovir is a approved stage product being developed by Gilead Sciences for HIV/AIDS. The current trial status is unknown. This product is registered under clinical trial identifier NCT03120494. Target conditions include HIV/AIDS.

Hype Score Breakdown

Clinical
30
Activity
20
Company
9
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT03120494ApprovedUNKNOWN

Competing Products

11 competing products in HIV/AIDS

See all competitors
ProductCompanyStageHype Score
MetforminMerckPhase 2/3
65
Elvitegravir, Cobicistat, TAF, FTC + Efavirenz, TDF, and 3TCGilead SciencesPre-clinical
22
Switch to E/C/FTC/TAF dailyGilead SciencesPhase 1/2
40
Biktarvy + SymtuzaGilead SciencesPhase 3
76
TruvadaGilead SciencesApproved
84
bictegravir/emtricitabine/tenofovir alafenamide (BIC/F/TAF) + Standard initiation of antiretroviral therapy (ART)Gilead SciencesApproved
84
ChAdOx1.HTI + MVA.HTI + GS-9620 + Placebo + Placebo Oral TabletGilead SciencesPhase 2
51
TDF/FTC 300mg/200mg fixed-dose combination tablets + TAF/FTC 25mg/200mg fixed-dose combination tabletsGilead SciencesPhase 3
76
MaravirocPfizerPhase 1
32
EfavirenzBristol Myers SquibbPre-clinical
22
Moxifloxacin + Placebo + EfavirenzBristol Myers SquibbPhase 1
32

Other Products from Gilead Sciences

Ranolazine + PlaceboApproved
84
Truvada + Atazanavir + RitonavirApproved
84
Truvada + efavirenzApproved
84
B/F/TAF + Atripla + B/F/TAF Placebo + Atripla PlaceboApproved
84
TDF + Placebo Vaginal Gel + Vaginal TFV Gel + Placebo TabletsApproved
84